Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-22 · accession 0001415889-22-008969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-23 | 2022-08-22 | HRMY | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +29.0K | 29.0K | New | +$695.3K |
| DM | 2022-08-23 | 2022-08-22 | HRMY | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $47.00 | -29.0K | 2,321 | -93% | -$1.36M |
| D | 2022-08-23 | 2022-08-22 | HRMY | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $0.00 | -29.0K | 86.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-22 | M | A | 28,971 | $24.00 | 28,971 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-22 | S | D | 2,321 | $47.56 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.41 to $47.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-08-22 | S | D | 26,650 | $46.95 | 2,321 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $47.39. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option | 2022-08-22 | M | D | 28,971 | $0.00 | 86,914 | D | $24.00 · — to 2030-08-18 | 28,971 Common Stock | (F5) The Form 4 filed by the reporting person on March 2, 2022, overstated the number of securities owned following the reported transaction by 200 shares. The amount of securities reported herein reflects the correct number of securities owned following the transactions reported on this Form 4. (F4) The stock option vests in five equal annual installments beginning on August 21, 2021. |